BRCA1 and cancer: Indeed, inhibition of USP1-UAF1 by the small molecule ML323 [283] destabilizes replication forks and decreases the viability of the BRCA1-deficient cells, suggesting that USP1 inhibitors may have potential therapeutic use in BRCA1-deficient cancers [284].